Latest Headlines

Latest Headlines

Japan researchers look to upset apple cart of pharma manufacturing costs

Using equipment the size of a card table and techniques borrowed from the oil industry, Japan researchers believe they have found a method of producing drugs at a fraction of the current costs.

Vietnam-made vaccines WHO-cleared for export

Vietnam has become the 39th nation cleared for global exports of the vaccines it makes, joining an increasingly crowded field of local champions to multinational heavyweights. The World Health Organization gave that clearance recently for a country that expects to be a leading producer within the next 20 to 30 years.

Indian drug firms eye 'paper tiger' status at home, clinical opportunities abroad

Many of the largest pharmaceutical firms operating in India are contemplating becoming "paper tigers," existing there only on paper, with facilities moved to other countries. Regulatory delays get the blame.

Taiwan drug regulator plans online database after drug recall spate

Taiwan's Ministry of Health and Welfare has had enough after 46 recalls the past two weeks from 32 different pharmaceutical companies. MHW is taking its case to the cloud.

Second OTC drug recall within a week in Taiwan

Taiwan drug authorities issued their second drug recall within a week for use of lower-grade ingredients in over-the-counter drugs, this time targeting 23 products of 19 Taiwan companies.

Sigma-Aldrich opens Asia-Pacific hub in Singapore as regional manufacturing, R&D grow

Sigma-Aldrich formally opened its Asia-Pacific headquarters in Singapore on Friday, the latest major supplier to pharmaceutical manufacturers and research institutions in Asia to stake out a base in the wealth city-state that has seen an explosion in state-of-the-art manufacturing operations.

Catalent wraps up a $52M manufacturing expansion

Catalent doubled its capacity at a Kentucky manufacturing facility, wrapping up a $52 million project with plans to add about 140 new workers.

China's big pharma companies get thumbs-up from Moody's on reform push

Moody's Investors Service has given a thumbs-up to the credit outlook for big Chinese pharmaceutical companies, noting that a reform push by the government for more market-friendly policies and stronger safety guidelines promises sweeping changes to an industry sometimes viewed with suspicion because of safety lapses.

IDT Australia release on FDA nod for 23 generics begs the question: Where's the beef?

Australia Stock Exchange-listed IDT Australia has issued another in a series of announcements about acquiring 23 generic drugs marketed in the United States, the latest release stating the U.S. FDA has noted the transfer of ownership to IDT.

India moves partially on bar codes for exported drugs by July

India drug authorities plan to impose bar-code rules on single cartons of exported drugs beginning July 1, but have deferred requiring the tags on individual bottles or vials of the products.